Home » Japan's Takeda Creates U.S. R&D Subsidiary for Antibody Drugs
Japan's Takeda Creates U.S. R&D Subsidiary for Antibody Drugs
Takeda Pharmaceutical Co. said Monday that it has established a research and development (R&D) subsidiary in the U.S. that will concentrate on therapeutic antibodies.
TradingMarkets
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May